The Israeli Urological Association and MSD Invites you to 3 Scientific Meetings:

Utilizing Immunotherapy in Urologic Practice - From Basics to Long Term Experience

Face to face meetings - Dan Acadia Hotel, Herzliya

Date Thursday, 15 July 2021

Date Thursday, 29 July 2021

Date Thursday, 12 August 2021

Time 17:30-21:00

desktop Dan Acadia Hotel,Herzliya, Ramot Yam 122


First Meeting 15-07

  • 17:30-18:00 Gathering + Opening
  • 18:00-19:00 Molecular Fundamentals and Rationale for Immunotherapy in Solid Tumors Prof. Gal Markel, Director of Davidoff & Deputy Director General, Rabin Medical Center
  • 19:00-20:00 Best Practice in Patient Management in I-O Era Dr. Ronnie Shapira, Chief Physician of the Ella Institute for Immuno-Oncology Center and Research of Melanoma and Skin Cancer at Sheba Medical Center
  • 20:00-20:15 Break
  • 20:15-21:00 The Importance of Multidisciplinary Treatment in Immunotherapy - The Nurse Perspective Yael Steinberg, Head Nurse of the Ella Institute for Immuno-Oncology Center Melanoma Treatment Center, Sheba Medical Center

Second Meeting 29-07

  • 17:30-18:00 Gathering
  • 18:00-19:00 The Rational and Evolvement of Systemic Therapy in Early Bladder Cancer Dr. Andrea Necchi, Associate Prof. Head of Genitourinary Medical Oncology San Raffaele, Milano, Italy
  • 19:00-19:30 Treatment Paradigm in NMIBC Prof. Amiel Gilad, Director Department of Urology, Rambam Health Care Campus, Israel
  • 19:30-20:00 The Evolvement of Immunotherapy in Advance Urothelial Cancer Dr. Avivit Peer, Head of Clinical Trials Unit, Head of Genitourinary clinic, Oncology Institute, Rambam Health Care Campus. Haifa, Israel
  • 20:00-20:15 Break
  • 20:15-21:00 Workshop - Cases Discussions in Groups Lead by Urologists and Oncologists

Third Meeting 12-08

  • 17:30-18:00 Gathering
  • 18:00-19:00 Immunotherapy in NMIBC – Clinical Aspects and Practical Management Dr. Arjun Vasant Balar, Associate Professor of Medicine Director – Genitourinary Medical Oncology Program, Medical Director – Clinical Trials Office Laura and Isaac Perlmutter Cancer Center An NCI-Designated Comprehensive Cancer Center
  • 19:00-19:45 Workshop - Cases Discussions in Groups Lead by Urologists and Oncologists
  • 19:45-20:00 Break
  • 20:00-20:30 Discussion and Proposals for Treatment Protocols for Optimal Management in the Hospitals Lead by Urologists
  • 20:30-21:00 Urologists Discussion - Next Steps in Data and Research IUOC Group